Government policies make Canada’s pharmaceutical environment less attractive to drug companies.
new drug approval
New drugs are approved later in Canada than in the United States and European Union.
Regardless of their potential impact on patient health, drug approval times in Canada were longer than in other countries.
Drugs were approved in the U.S. 469 days earlier (on average) than in Canada.
Innovative new medicines can have a profound impact on the health and wellbeing of those stricken with illness. Unfortunately, Canadians are often denied these benefits for months, if not years, while they wait for their government to approve drugs already deemed safe and effective by regulators in the European Union and United States. Smarter regulation could save resources, reduce patient suffering, and improve the lives of Canadians.